These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995. Lee YC; McCrystal MR; Christmas TI N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564 [TBL] [Abstract][Full Text] [Related]
4. [Combined radiotherapy and chemotherapy modalities in the treatment of lung cancer]. Furuse K; Kawahara M; Arai R; Kodama N; Yamamoto M; Kubota K; Ogawara M; Nakai R Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1628-33. PubMed ID: 2837998 [TBL] [Abstract][Full Text] [Related]
5. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy]. Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515 [TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy for stage III non-small cell lung cancer. Stinchcombe TE; Fried D; Morris DE; Socinski MA Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of the unresectable non small cell lung carcinoma]. Spásová I Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938 [TBL] [Abstract][Full Text] [Related]
8. Triplet chemotherapy combinations with new agents: is there a rationale? Bunn PA Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586 [TBL] [Abstract][Full Text] [Related]
9. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420 [TBL] [Abstract][Full Text] [Related]
10. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer. Belani CP Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783 [TBL] [Abstract][Full Text] [Related]
11. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer. Brugger W; Fetscher S; Hasse J; Frommhold H; Pressler K; Mertelsmann R; Engelhardt R; Kanz L Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211 [TBL] [Abstract][Full Text] [Related]
12. [Combined modality treatment of chemotherapy and radiotherapy for unresectable non-small cell lung cancer]. Kubota K Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():384-9. PubMed ID: 9369912 [TBL] [Abstract][Full Text] [Related]
14. [Recent progress and perspectives in the management of patients with lung cancer]. Barlesi F; Gimenez C; Pibarot M; Kleisbauer JP Bull Cancer; 2002 Jan; 89(1):57-66. PubMed ID: 11847027 [TBL] [Abstract][Full Text] [Related]
15. [Long-term survivors of non-small cell lung cancer treated with non-surgical therapeutic modalities]. Fujii M; Segawa Y; Matsutomo S; Kimura M Gan No Rinsho; 1990 Apr; 36(5):589-92. PubMed ID: 2157905 [TBL] [Abstract][Full Text] [Related]